3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
117
Stomach Neoplasms
21
HER2-positive Breast Cancer
14
Neoplasm Metastasis
13
Neoplasms
12
Colorectal Neoplasms
11
Esophageal Neoplasms
9
Triple Negative Breast Neoplasms
5
Lung Neoplasms
5
Colonic Neoplasms
5
Carcinoma, Non-Small-Cell Lung
5
Brain Neoplasms
5
Rectal Neoplasms
4
Ovarian Neoplasms
4
Meningeal Neoplasms
4
Endometrial Neoplasms
4
Biliary Tract Neoplasms
4
Adenocarcinoma Of Esophagus
4
Uterine Cervical Neoplasms
3
Salivary Gland Neoplasms
3
Prostatic Neoplasms
3
Pancreatic Neoplasms
3
Multiple Myeloma
3
Meningeal Carcinomatosis
3
Lymphoma, Non-Hodgkin
3
Inflammatory Breast Neoplasms
3
Hematologic Neoplasms
3
Gallbladder Neoplasms
3
Breast Diseases
3
Anatomic Stage I Breast Cancer AJCC v8
3
Interventions
pembrolizumab
5
Specimen Handling
4
Magnetic Resonance Spectroscopy
4
cabozantinib
3
Nivolumab
3
cemiplimab
2
Ipilimumab
2
sodium thiosulfate
1
relacorilant
1
lenvatinib
1
fludarabine phosphate
1
dostarlimab
1
Radiation
1
Mitotane
1
Interleukin-13
1
Fluorodeoxyglucose F18
1
Floxuridine
1
E-7386
1
Drug Therapy
1
Dexamethasone
1
Cytoreduction Surgical Procedures
1
Cyclophosphamide
1
Cisplatin
1
CTLA-4 Antigen
1
Biopsy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Adrenocortical Carcinoma
×
Trastuzumab
×
1 year
×
Clear all
No trials found.